St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Massive Iron Deposit Assessment

Not Applicable

Completed

Conditions: Excessive Body Iron Burden
Iron Overload

Interventions: Device: R2*-UTE
Device: R2*-GRE
Procedure: Liver biopsy

First Posted Date: 2012-04-06

Last Posted Date: 2019-06-11

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 142

Registration Number: NCT01572922

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program

Completed

Conditions: Sickle Cell Disease

Interventions: Other: Assessment

First Posted Date: 2012-04-03

Last Posted Date: 2014-06-24

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 55

Registration Number: NCT01569971

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant

Completed

Conditions: Solid Tumor
Brain Tumor
Lymphoma

Interventions: Other: Blood samples obtained

First Posted Date: 2012-02-28

Last Posted Date: 2015-07-14

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 31

Registration Number: NCT01540175

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants

Phase 1

Suspended

Conditions: Severe Combined Immunodeficiency Disease, X-linked

Interventions: Genetic: CL20-i4-EF1α-hγc-OPT
Drug: Busulfan
Device: CliniMacs

First Posted Date: 2012-01-19

Last Posted Date: 2024-04-17

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 28

Registration Number: NCT01512888

Locations: 🇺🇸
University of California-San Francisco, San Francisco, California, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
Seattle Children's Research Institute, Seattle, Washington, United States

Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)

Phase 2

Completed

Conditions: Neuropathic Pain
Acute Lymphoblastic Leukemia
Neuropathy

Interventions: Drug: gabapentin
Drug: placebo

First Posted Date: 2012-01-10

Last Posted Date: 2019-06-19

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 51

Registration Number: NCT01506453

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma

Phase 1

Completed

Conditions: Central Nervous System Malignancies
Ependymoma

Interventions: Drug: 5-fluorouracil

First Posted Date: 2011-12-23

Last Posted Date: 2016-02-02

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 26

Registration Number: NCT01498783

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

The Feasibility Of a Daily Diary Methodology With a Pediatric Cancer Population

Completed

Conditions: Cancer

Interventions: Behavioral: iPad

First Posted Date: 2011-11-22

Last Posted Date: 2016-04-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 154

Registration Number: NCT01477255

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Adolescent Loss: The Impact of Loss on Adolescent Oncology Patients

Completed

Conditions: Adolescent Oncology Patients

First Posted Date: 2011-11-17

Last Posted Date: 2016-08-12

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 153

Registration Number: NCT01473862

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection

Phase 3

Completed

Conditions: Central Line-Associated Bloodstream Infection

Interventions: Drug: heparin-saline placebo
Drug: ethanol

First Posted Date: 2011-11-17

Last Posted Date: 2017-11-13

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 95

Registration Number: NCT01472965

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇦🇺
Royal Children's Hospital Melbourne, Parkville, Victoria, Australia

NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma

Phase 2

Completed

Conditions: Lymphoblastic Lymphoma

Interventions: Drug: Prednisone
Drug: Vincristine
Drug: Daunorubicin
Drug: PEG-asparaginase
Drug: Erwinia asparaginase
Drug: Doxorubicin
Drug: Cyclophosphamide
Drug: Cytarabine
Drug: Thioguanine
Drug: Clofarabine
Drug: Methotrexate
Drug: Mercaptopurine
Drug: Dexamethasone
Drug: Hydrocortisone
Drug: Etoposide

First Posted Date: 2011-10-13

Last Posted Date: 2022-06-28

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 23

Registration Number: NCT01451515

Locations: 🇺🇸
Rady Children's Hospital San Diego, San Diego, California, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy